Log in to save to my catalogue

APOE3 Christchurch Heterozygosity and Autosomal Dominant Alzheimer’s Disease

APOE3 Christchurch Heterozygosity and Autosomal Dominant Alzheimer’s Disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3122638922

APOE3 Christchurch Heterozygosity and Autosomal Dominant Alzheimer’s Disease

About this item

Full title

APOE3 Christchurch Heterozygosity and Autosomal Dominant Alzheimer’s Disease

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2024-10, Vol.391 (17), p.1660-1661

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

To the Editor:
The report by Quiroz et al. (June 20 issue)
1
on the Colombian
PSEN1
E280A
pedigree suggests a protective effect of apolipoprotein E3 Christchurch (
APOE3
Ch
) variant heterozygosity. The signal from 27 carriers is driven by 13 carriers in whom mild cognitive impairment or dementia developed. A previous stu...

Alternative Titles

Full title

APOE3 Christchurch Heterozygosity and Autosomal Dominant Alzheimer’s Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3122638922

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3122638922

Other Identifiers

ISSN

0028-4793,1533-4406

E-ISSN

1533-4406

DOI

10.1056/NEJMc2409320

How to access this item